Morgan Stanley raised the firm’s price target on UnitedHealth (UNH) to $395 from $325 and keeps an Overweight rating on the shares after the company was the first MCO in the analyst’s coverage to disclose expectations around 2026 Medicare Advantage Star Ratings with a positive update. Centene (CNC) subsequently spoke yesterday morning, pointing to an expectation of a slightly better percentage of membership in 4+ Star plans versus early none this year, the analyst noted. Earlier in the week, CVS Health (CVS) “took a more balanced approach to Stars commentary, added the analyst, who says CVS remains among the national MA players that has yet to formally release 4+ Star membership expectations along with Humana (HUM) and Elevance Health (ELV).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Morgan Stanley Beats the Drum for UnitedHealth (UNH) Stock — But Can It Climb Higher?
- UnitedHealth (UNH) Stock Wins a Price Target Boost from Top UBS Analyst
- Humana price target raised to $330 from $312 at BofA
- UnitedHealth price target raised to $350 from $325 at BofA
- Mixed options sentiment in UnitedHealth with shares down 1.16%